LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,790 | -83.7% | 26,652 | -83.2% | 0.02% | -75.9% |
| Q2 2023 | $10,981 | +45.4% | 159,076 | +1.6% | 0.08% | -5.7% |
| Q1 2023 | $7,552 | +5.9% | 156,623 | +9.6% | 0.09% | +1.1% |
| Q4 2022 | $7,133 | -99.9% | 142,891 | +3.8% | 0.09% | +24.3% |
| Q3 2022 | $5,615,000 | -27.4% | 137,625 | -2.2% | 0.07% | -14.6% |
| Q2 2022 | $7,739,000 | +38.1% | 140,716 | -8.8% | 0.08% | +100.0% |
| Q1 2022 | $5,604,000 | -58.9% | 154,215 | -47.2% | 0.04% | -44.6% |
| Q4 2021 | $13,621,000 | – | 292,225 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |